Riskpilot← Back to searchSign inGet full accessLPS Biosolutions A/S
A/SActiveCVR 31286204Brydehusvej 30LResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200824 employees
Revenue 2024
DKK -2,7M
-253% vs 2023
EBITDA margin
395.9%
-102% vs 2023
Equity ratio
42.7%
Financial strength
Net profit 2024
DKK -10,4M
-81% vs 2023
| Revenue | DKK -2,7M | -253% |
| EBITDA | DKK -10,5M | -102% |
| Net profit | DKK -10,4M | -81% |
| Total assets | DKK 26,8M | +57% |
| Equity | DKK 11,4M | +31% |
| Employees | 24 | — |
Legal name
LPS Biosolutions A/S
CVR number
31286204
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29. februar 2008
Share capital
DKK 472.536
Employees
24 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er at udvikle, producere og sælge produkter og sælge licenser inden for fødevarer og bioteknologi.
Address
Brydehusvej 30L
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | -7 | 25 | 760 | 10.179 | 17.082 | 5.565 | 4.347 | 3.017 | 1.739 | -2.656 |
| Staff expenses | -0 | -0 | -0 | -0 | -305 | -493 | -3.490 | -4.740 | -4.867 | -3.188 | -6.085 | -6.947 | -7.862 |
| EBITDA | -11 | 386 | -10 | -7 | -280 | 267 | 6.689 | 12.342 | 698 | 1.158 | -3.069 | -5.208 | -10.518 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -78 | -165 | -180 | -332 | -501 | -719 | -1.030 | -1.523 | -1.935 |
| EBIT | -11 | 386 | -10 | -7 | -358 | 102 | 6.509 | 12.011 | 197 | 439 | -4.099 | -6.731 | -12.453 |
| Net financials | 0 | 25 | 570 | -38 | 329 | -90 | -509 | -242 | -99 | -266 | -269 | -781 | -1.071 |
| Profit before tax | -11 | 361 | -585 | -45 | -29 | 13 | 6.000 | 11.769 | 98 | 173 | -4.368 | -7.512 | -13.524 |
| Tax | -0 | 96 | -0 | -0 | -0 | -0 | 728 | 2.625 | -388 | -508 | -1.526 | -1.782 | -3.163 |
| Net profit | -11 | 264 | -585 | -45 | -29 | 13 | 5.271 | 9.144 | 485 | 681 | -2.842 | -5.730 | -10.362 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 | 824 | 112 | 36 | 2.009 | 2.564 | 6.575 | 13.723 | 11.602 | 14.284 | 19.072 | 17.013 | 26.775 |
| Equity | -21 | 243 | -342 | -386 | -415 | -403 | 4.869 | 10.012 | 10.498 | 8.179 | 12.606 | 8.717 | 11.431 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.000 | 4.000 | 3.000 | 7.563 |
| Short-term debt | 27 | 581 | 454 | 392 | 2.394 | 2.937 | 1.676 | 3.699 | 1.104 | 1.105 | 2.466 | 5.187 | 7.782 |
| Total debt | 27 | 581 | 454 | 392 | 2.394 | 2.937 | 1.676 | 3.699 | 1.104 | 6.105 | 6.466 | 8.187 | 15.345 |
EBITDA margin
-1051814500.0%
This company
15.8%
Market median
-6657053897% vs market
20122024
Equity ratio
42.7%
This company
38.2%
Market median
+12% vs market
20122024
Return on equity
-90.6%
This company
18.4%
Market median
-592% vs market
20122024
Net profit margin
-1036160700.0%
This company
8.1%
Market median
-12792107507% vs market
20122024
Asset turnover
-0.10×
This company
1.12×
Market median
-109% vs market
20122024
Debt / equity
1.34×
This company
0.62×
Market median
-116% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Founder | Founder | 2008 | — | — |
AO Management | Management | 2025 | — | — |
KL Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Deputy Chairman | 2016 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
LIHMES ApS | Company | 25.0% | 25.0% | 2025 |
BERGUS ApS | Company | 10.0% | 10.0% | 2023 |
You are We ApS | Company | 5.0% | 5.0% | 2024 |
| Individual | 5.0% | 5.0% | 2024 | |
| Individual | 5.0% | 5.0% | 2025 | |
CHR. OLESEN A/S | Company | 5.0% | 5.0% | 2024 |
HC HANDEL & INVEST ApS | Company | 5.0% | 5.0% | 2025 |
Bendix Protein Consulting ApS | Company | 5.0% | 5.0% | 2024 |
DANISH AGRO A.M.B.A. | Company | 5.0% | 5.0% | 2025 |
You Group Care ApS | Company | 5.0% | 5.0% | 2024 |
| Individual | 10.0% | 10.0% | 2022 | |
| Individual | 15.0% | 15.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Chr. Olesen Holding II A/S
LPS Biosolutions A/S Board members of LPS Biosolutions A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirsten Bisgaard-Frantzen | Founder | 0 companies |
| Allan Otto Fog Lihme | Management | 0 companies |
| Karsten Lindved | Chief Executive Officer | 0 companies |
| Henrik Christensen | Board of Directors | 0 companies |
| Jens Christian Mathiesen | Deputy Chairman | 0 companies |
| Filippo Marchi | Board of Directors | 0 companies |
| Ivan Noes | Board of Directors | 0 companies |
| Anders Weber | Chairman | 0 companies |
| Christian Dam Olesen | Board of Directors | 0 companies |